These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 21204603

  • 1. Immunization with DNA vaccine expressing herpes simplex virus type 1 gD and IL-21 protects against mouse herpes keratitis.
    Hu K, He X, Yu F, Yuan X, Hu W, Liu C, Zhao F, Dou J.
    Immunol Invest; 2011; 40(3):265-78. PubMed ID: 21204603
    [Abstract] [Full Text] [Related]

  • 2. An ocular mucosal administration of nanoparticles containing DNA vaccine pRSC-gD-IL-21 confers protection against mucosal challenge with herpes simplex virus type 1 in mice.
    Hu K, Dou J, Yu F, He X, Yuan X, Wang Y, Liu C, Gu N.
    Vaccine; 2011 Feb 04; 29(7):1455-62. PubMed ID: 21185849
    [Abstract] [Full Text] [Related]

  • 3. Preventive effect of local plasmid DNA vaccine encoding gD or gD-IL-2 on herpetic keratitis.
    Inoue T, Inoue Y, Nakamura T, Yoshida A, Takahashi K, Inoue Y, Shimomura Y, Tano Y, Fujisawa Y, Aono A, Hayashi K.
    Invest Ophthalmol Vis Sci; 2000 Dec 04; 41(13):4209-15. PubMed ID: 11095617
    [Abstract] [Full Text] [Related]

  • 4. [Enhancement of herpes simplex virus-1 glycoprotein-D DNA vaccine induced specific immune responses by coimmunization with interleukin-2 genetic adjuvant].
    Liu XJ, Zhu MZ, Song GX, Xu YF, Liu HW, Wang S, Yang BL, Dong FT, Xu XM.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb 04; 27(1):67-72. PubMed ID: 15782496
    [Abstract] [Full Text] [Related]

  • 5. IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge.
    Sin JI, Kim JJ, Arnold RL, Shroff KE, McCallus D, Pachuk C, McElhiney SP, Wolf MW, Pompa-de Bruin SJ, Higgins TJ, Ciccarelli RB, Weiner DB.
    J Immunol; 1999 Mar 01; 162(5):2912-21. PubMed ID: 10072541
    [Abstract] [Full Text] [Related]

  • 6. Topical Administration Is a Promising Inoculating Route versus Intramuscular Inoculation for the Nanoparticle-Carried DNA Vaccine to Prevent Corneal Infections.
    Hu K, Malla T, Zhai Y, Dong L, Tang R.
    Ophthalmic Res; 2015 Mar 01; 55(2):99-110. PubMed ID: 26650397
    [Abstract] [Full Text] [Related]

  • 7. The efficacy of a DNA vaccine encoding herpes simplex virus type 1 (HSV-1) glycoprotein D in decreasing ocular disease severity following corneal HSV-1 challenge.
    Frye TD, Chiou HC, Hull BE, Bigley NJ.
    Arch Virol; 2002 Sep 01; 147(9):1747-59. PubMed ID: 12209314
    [Abstract] [Full Text] [Related]

  • 8. Coexpression of interleukin-2 enhances the immunization effect of a DNA vaccine expressing herpes simplex 1 glycoprotein D.
    Li WR, Niu B, Wang JW, Feng ZJ, Wang DX.
    Acta Virol; 2006 Sep 01; 50(4):251-6. PubMed ID: 17177610
    [Abstract] [Full Text] [Related]

  • 9. CpG oligodeoxynucleotide augments HSV-2 glycoprotein D DNA vaccine efficacy to generate T helper 1 response and subsequent protection against primary genital herpes infection in mice.
    Tengvall S, Josefsson A, Holmgren J, Harandi AM.
    J Reprod Immunol; 2005 Dec 01; 68(1-2):53-69. PubMed ID: 16229896
    [Abstract] [Full Text] [Related]

  • 10. Immunization with dendritic cell-based DNA vaccine pRSC-NLDC145.gD-IL21 protects mice against herpes simplex virus keratitis.
    Tang R, Zhai Y, Dong L, Malla T, Hu K.
    Immunotherapy; 2018 Mar 01; 10(3):189-200. PubMed ID: 29370719
    [Abstract] [Full Text] [Related]

  • 11. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines.
    Bettahi I, Nesburn AB, Yoon S, Zhang X, Mohebbi A, Sue V, Vanderberg A, Wechsler SL, BenMohamed L.
    Invest Ophthalmol Vis Sci; 2007 Oct 01; 48(10):4643-53. PubMed ID: 17898288
    [Abstract] [Full Text] [Related]

  • 12. [Enhancement of cellular immune response to DNA vaccine encoding hepatitis C virus core and envelope 2 fusion antigen by murine Fms-like tyrosine kinase 3 ligand].
    Ke JS, Zhao P, Cao J, Yu JP, Qi ZT.
    Sheng Wu Gong Cheng Xue Bao; 2003 Mar 01; 19(2):158-62. PubMed ID: 15966314
    [Abstract] [Full Text] [Related]

  • 13. Protection against herpes simplex virus-induced eye disease after vaccination with seven individually expressed herpes simplex virus 1 glycoproteins.
    Ghiasi H, Bahri S, Nesburn AB, Wechsler SL.
    Invest Ophthalmol Vis Sci; 1995 Jun 01; 36(7):1352-60. PubMed ID: 7775113
    [Abstract] [Full Text] [Related]

  • 14. Prime-boost immunization with DNA and modified vaccinia virus ankara vectors expressing herpes simplex virus-2 glycoprotein D elicits greater specific antibody and cytokine responses than DNA vaccine alone.
    Meseda CA, Elkins KL, Merchlinsky MJ, Weir JP.
    J Infect Dis; 2002 Oct 15; 186(8):1065-73. PubMed ID: 12355355
    [Abstract] [Full Text] [Related]

  • 15. Intravascular naked DNA vaccine encoding glycoprotein B induces protective humoral and cellular immunity against herpes simplex virus type 1 infection in mice.
    Cui FD, Asada H, Kishida T, Itokawa Y, Nakaya T, Ueda Y, Yamagishi H, Gojo S, Kita M, Imanishi J, Mazda O.
    Gene Ther; 2003 Dec 15; 10(25):2059-66. PubMed ID: 14595378
    [Abstract] [Full Text] [Related]

  • 16. Effect of herpes simplex virus-1 gD or gD-IL-2 DNA vaccine on herpetic keratitis.
    Inoue T, Inoue Y, Hayashi K, Shimomura Y, Fujisawa Y, Aono A, Tano Y.
    Cornea; 2002 Oct 15; 21(7 Suppl):S79-85. PubMed ID: 12484704
    [Abstract] [Full Text] [Related]

  • 17. Cytokine genetic adjuvant facilitates prophylactic intravascular DNA vaccine against acute and latent herpes simplex virus infection in mice.
    Cui FD, Asada H, Jin ML, Kishida T, Shin-Ya M, Nakaya T, Kita M, Ishii M, Iwai M, Okanoue T, Imanishi J, Mazda O.
    Gene Ther; 2005 Jan 15; 12(2):160-8. PubMed ID: 15470476
    [Abstract] [Full Text] [Related]

  • 18. Plasmid DNA-expressed secreted and nonsecreted forms of herpes simplex virus glycoprotein D2 induce different types of immune responses.
    Higgins TJ, Herold KM, Arnold RL, McElhiney SP, Shroff KE, Pachuk CJ.
    J Infect Dis; 2000 Nov 15; 182(5):1311-20. PubMed ID: 11023455
    [Abstract] [Full Text] [Related]

  • 19. [The effect of immunization with herpes simplex virus glycoprotein D fused with interluekin-2 against murine herpetic keratitis].
    Inoue T, Inoue Y, Nakamura T, Yoshida A, Inoue Y, Tano Y, Shimomura Y, Fujisawa Y, Aono A, Hayashi K.
    Nippon Ganka Gakkai Zasshi; 2001 Apr 15; 105(4):223-9. PubMed ID: 11329945
    [Abstract] [Full Text] [Related]

  • 20. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
    Ritchie MH, Oakes JE, Lausch RN.
    Invest Ophthalmol Vis Sci; 1993 Jul 15; 34(8):2460-8. PubMed ID: 8392037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.